IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GEROSA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.686
EU - Europa 8.414
AS - Asia 6.787
SA - Sud America 1.232
AF - Africa 204
OC - Oceania 138
Continente sconosciuto - Info sul continente non disponibili 9
Totale 25.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.846
CN - Cina 2.799
GB - Regno Unito 1.999
IT - Italia 1.415
SG - Singapore 1.339
DE - Germania 1.220
ES - Italia 681
HK - Hong Kong 617
BR - Brasile 591
SE - Svezia 496
RU - Federazione Russa 488
JP - Giappone 487
FR - Francia 477
CA - Canada 405
IN - India 379
MX - Messico 378
NL - Olanda 337
CO - Colombia 238
IE - Irlanda 212
AR - Argentina 166
ID - Indonesia 149
KR - Corea 147
TR - Turchia 147
VN - Vietnam 147
UA - Ucraina 128
AU - Australia 124
DK - Danimarca 119
PL - Polonia 118
FI - Finlandia 109
GR - Grecia 106
CH - Svizzera 100
BE - Belgio 89
SA - Arabia Saudita 83
TW - Taiwan 83
TH - Thailandia 73
PE - Perù 64
IL - Israele 60
EG - Egitto 54
RO - Romania 54
EC - Ecuador 53
AT - Austria 49
PT - Portogallo 49
CI - Costa d'Avorio 47
CL - Cile 40
EU - Europa 39
IR - Iran 36
VE - Venezuela 36
BD - Bangladesh 32
UY - Uruguay 31
ZA - Sudafrica 30
PH - Filippine 29
NO - Norvegia 26
MY - Malesia 25
PK - Pakistan 24
RS - Serbia 22
JO - Giordania 20
CZ - Repubblica Ceca 19
IQ - Iraq 19
KE - Kenya 18
HU - Ungheria 16
BA - Bosnia-Erzegovina 14
BG - Bulgaria 13
HR - Croazia 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
NZ - Nuova Zelanda 12
UZ - Uzbekistan 12
MA - Marocco 11
DO - Repubblica Dominicana 9
LV - Lettonia 9
BO - Bolivia 8
GT - Guatemala 8
LB - Libano 8
LT - Lituania 8
DZ - Algeria 7
ET - Etiopia 7
KZ - Kazakistan 7
NI - Nicaragua 7
SI - Slovenia 7
PA - Panama 6
QA - Qatar 6
PR - Porto Rico 5
PY - Paraguay 5
AL - Albania 4
AM - Armenia 4
AZ - Azerbaigian 4
BY - Bielorussia 4
CR - Costa Rica 4
CY - Cipro 4
EE - Estonia 4
JM - Giamaica 4
KW - Kuwait 4
LK - Sri Lanka 4
CU - Cuba 3
GE - Georgia 3
HN - Honduras 3
LU - Lussemburgo 3
MN - Mongolia 3
MV - Maldive 3
OM - Oman 3
Totale 25.452
Salva come PNG Salva come JPEG
Città #
Southend 1.446
Singapore 772
Dallas 734
Ashburn 657
Milan 491
Chandler 484
Hong Kong 483
Beijing 430
Seattle 261
Hanover 255
Redwood City 233
New York 232
Fairfield 225
Princeton 202
Wilmington 199
Frankfurt am Main 193
Dublin 192
Santa Clara 183
Council Bluffs 174
Hefei 169
Ann Arbor 161
Munich 160
Tokyo 145
Shanghai 143
Los Angeles 140
Nanjing 137
Houston 135
Guangzhou 133
Woodbridge 130
Dearborn 129
Bengaluru 125
Madrid 118
Montréal 113
Bogotá 102
Cambridge 99
Moscow 95
Buffalo 92
Chicago 90
Jacksonville 88
Mcallen 87
Jakarta 83
Toronto 83
Des Moines 80
São Paulo 80
Hangzhou 72
Jinan 69
Mexico City 69
Changsha 65
Columbus 63
Barcelona 62
Phoenix 58
Berlin 55
Warsaw 55
Paris 51
Granada 49
Mountain View 49
Taipei 48
The Dalles 48
Abidjan 47
Athens 47
Lima 47
London 47
Boardman 46
Brooklyn 46
Chengdu 45
Rome 44
Buenos Aires 42
Istanbul 42
Fuzhou 41
Medellín 41
Ho Chi Minh City 40
Zhengzhou 39
Redmond 38
Shenyang 38
Tianjin 38
Seoul 36
Cangzhou 35
Córdoba 35
Helsinki 35
Boston 34
Ottawa 34
Nuremberg 33
Riyadh 33
Sunnyvale 33
Brussels 32
Hanoi 32
San Diego 32
Chongqing 31
Wuhan 31
Jeddah 30
Andover 28
Fremont 28
Osaka 27
Zurich 27
Central District 26
Hamburg 26
Hebei 26
Hyderabad 26
Serra 26
Stockholm 26
Totale 13.066
Salva come PNG Salva come JPEG
Nome #
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 4.799
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases 2.017
Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study 1.320
IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus 828
Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications 502
Complement activation in anti-phospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery 455
P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus 365
Are patients with systemic lupus erythematosus at increased risk for COVID-19? 339
Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis 292
Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome 283
COVID-19 in systemic lupus erythematosus : data from a survey on 417 patients 283
Pidotimod : a reappraisal 269
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 242
Circulating stem cell factor in patients with chronic idiopathic urticaria 238
Identification of a Shared Microbiomic and Metabolomic Profile in Systemic Autoimmune Diseases 234
Evidence for a pathogenic role of extrafollicular, IL-10–producing CCR6+B helper T cells in systemic lupus erythematosus 227
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers 205
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 204
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus 198
Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies 190
Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome 188
Disease knowledge index and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 188
Cardiac involvement in systemic autoimmune diseases 187
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 185
Up-date on the antiphospholipid syndrome 182
Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 178
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide : a phase II pilot study 176
Patients with antiphospholipid syndrome display endothelial perturbation 173
Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss 171
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs : an Italian multicentre study 168
The Risk of Obstetric Complications and the Effects of Treatment in Women with Low Titer and Medium-High Titer Anti-Phospholipid Antibodies 167
Endothelium as a target for antiphospholipid antibodies 164
Systemic Lupus erythematosus complicated by thrombotic thrombocytopenic purpura 164
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study 163
Production of anti-{PF}4 antibodies in antiphospholipid antibody-positive patients is not affected by {COVID}-19 vaccination 162
Antiphospholipid antibodies and ex-vivo endothelial perturbation 158
Rheumatoid arthritis : a female challenge 158
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 157
Statins and autoimmune diseases 156
Antiphospholipid syndrome and systemic lupus erythematosus patients: what's new about cognitive involvement? 155
Anti-DNA antibodies : a diagnostic and prognostic tool for systemic lupus erythematosus? 153
Diagnostic, research, and real-life effect of the 2023 EULAR−ACR classification criteria for antiphospholipid syndrome 152
Anti-NR2 antibodies and primary antiphospholipid syndrome : a preliminary study 151
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block : an Italian multicentre cross-sectional study on behalf of the "Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group" 150
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus 149
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2-glycoprotein i domain 1 and domain 4/5 : ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome 149
Counseling on family planning and contraception in patients with rheumatic diseases : Analysis of 324 patient-reported questionnaires from a multicenter Italian study 149
The Efficacy of Treatment with Low Dose Aspirin and Low Molecular Weight Heparin in Pregnant Women with Criteria Anti-Phospholipid Antibodies 146
Defective regulation by ATP-GATED ionotropic P2X7 receptor drives T follicular helper cell expansion in systemic lupus erythematosus 145
Antibodies Against Domain 1 and Domain 4/5 of β2 Glycoprotein I : Clinical Relevance in Obstetric Anti-Phospholipid Syndrome 144
IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases 142
Diversity and somatic hypermutation of the Ig VHDJH, V kappa J kappa, and V lambda J lambda gene segments in lymphoma B cells : relevance to the origin of the neoplastic B cell clone 140
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 138
Obstetric antiphospholipid syndrome: Lobsters only? or should we also look for selected red herrings? 135
Management of the controversial aspects of the antiphospholipid syndrome pregnancies : a guide for clinicians and researchers 134
Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome 130
Chronic urticaria : new immunologic aspects 129
Pregnancy outcomes in women exposed to biologic treatment and affected by chronic arthritis 128
Primary Antiphospholipid Syndrome Patients Display Increased Levels of Cell-Bound C4d in Comparison to SLE and Healthy Donors 127
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 126
Challenges and treatment options for rheumatoid arthritis during pregnancy 126
Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases 122
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 120
Measurement of electrical skin impedance of dermal-visceral zones as a diagnostic tool for disorders of the immune system 118
Update on pregnancy in autoimmune diseases 116
Antiphospholipid syndrome and systemic lupus erythematosus patients: what's new about cognitive involvement? 115
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases) 115
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome 115
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases 115
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases 113
Transforming growth factor beta1 in the pathogenesis of autoimmune congenital complete heart block : lesson from twins and triplets discordant for the disease 113
Lung Disease in Antiphospholipid Syndrome 113
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies 112
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study 108
Succesfull sequential therapy with rituximab and belimumab in three patients with active systemic lupus erythematosus 106
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases 101
Differential impairment of serum cholesterol efflux capacity in patients with rheumatoid arthritis and systemic lupus erythematosus 100
Pregnancy in juvenile idiopathic arthritis: maternal and foetal outcome, and impact on disease activity 100
Primary anti-phospholipid syndrome : any role for serum complement levels in predicting pregnancy complications? 99
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No 99
Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction 97
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases 96
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting : results of a large, multicentric, nationwide study 96
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up 96
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study 94
Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study 94
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients 94
Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies 93
Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants 91
Successful sequential therapy with rituximab and belimumab in patients with active systemic lupus erythematosus: a case series 91
Investigating the role of Endothelial Dysfunction in Antiphospholipid Syndrome by using Patient-Specific Endothelial Colony-Forming Cells 90
Safety considerations when prescribing immunosuppression medication to pregnant women 90
Anti-phospholipid antibodies and reproductive failures 89
The use of biologics and small molecules in pregnant patients with rheumatic diseases 88
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity : a European multicentre retrospective study 87
Recognition and management of antiphospholipid syndrome 87
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients : Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository 85
Cardiovascular Issues in SLE 84
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study) 83
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients 83
Totale 23.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.631
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.939 0 0 0 0 216 207 144 195 267 250 360 300
2021/20223.276 275 258 245 292 293 187 244 250 310 299 232 391
2022/20233.365 303 291 273 259 303 397 203 262 334 212 306 222
2023/20242.978 167 250 197 256 595 195 203 204 121 180 274 336
2024/20254.935 219 459 217 448 427 286 275 470 321 476 469 868
2025/20264.258 838 620 1.316 1.077 407 0 0 0 0 0 0 0
Totale 26.468